PARP Inhibitors Quick Guide — Understanding The Different Drugs & Who May Benefit February 3, 2022By Alison Maxwell
Women with Recurrent Ovarian Cancer Are Living Longer on PARP Inhibitors January 2, 2022By Ramtin Talebi
Homologous Recombination Deficiency (HRD): What it Is, and How it Might Affect Your Treatment December 5, 2021By Jordan Reed
New Research on Treatment for Ovarian Cancer: More Women Are Now Eligible to Receive a PARP Inhibitor November 5, 2021By Caroline Hopkins
